Response assessment using (68)Ga-PSMA ligand PET in patients undergoing (177)Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer

PURPOSE: The first aim of this study was to evaluate (68)Ga-PSMA(HBED-CC) conjugate 11 positron emission tomography (PSMA PET) parameters for assessment of response to (177)Lu-PSMA-617 radioligand therapy (RLT) in patients with metastatic castration-resistant prostate cancer (mCRPC). The second aim...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Nucl Med Mol Imaging
Main Authors: Grubmüller, Bernhard, Senn, Daniela, Kramer, Gero, Baltzer, Pascal, D’Andrea, David, Grubmüller, Karl Hermann, Mitterhauser, Markus, Eidherr, Harald, Haug, Alexander R., Wadsak, Wolfgang, Pfaff, Sarah, Shariat, Shahrokh F., Hacker, Marcus, Hartenbach, Markus
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6451716/
https://ncbi.nlm.nih.gov/pubmed/30569186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4236-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados